New steroid shot may keep surgery patients from feeling sick

NCT ID NCT06981754

First seen Jun 26, 2026 · Last updated Jul 02, 2026 · Updated 3 times

Summary

This study tests whether a single injection of dexamethasone palmitate, a long-acting steroid, can better prevent nausea and vomiting after minimally invasive surgery compared to standard dexamethasone. About 588 adults aged 18 to 65 having laparoscopic or thoracoscopic surgery will take part. The goal is to see if the new drug reduces the number of people who feel sick within 24 hours after their operation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
dexamethasone palmitate
What this could lead to
If it works, this could offer a more effective way to prevent nausea and vomiting after surgery, reducing discomfort for patients.
What could go wrong
This is an early-stage trial with no phase specified, so results are uncertain. The improvement over standard dexamethasone may be small, and side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEXAMETHASONE PALMITATE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Postoperative Nausea and Vomiting

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beijing Tiantan Hospital

    Beijing, Beijing Municipality, 100070, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.